UBS Lux Equity Fund Biotech USD vs Proethos Fond

UBS Lux Equity Fund Biotech USD vs Proethos Fond

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

2. Proethos Fond

  • Security

    Proethos Fond

  • Fee

    0.65%

  • ISIN

    SE0010547778

  • Holdings

    9

Fund Holdings

We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.35) and Moderna (9.21). In comparison with Proethos Fond, we have 11 holdings where Storebrand Grön Obligation A SEK is the largest holding (9.14), followed by Shimano (5.63) and Vestas (5.47).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Proethos Fond.

UBS Lux Equity Fund Biotech USD Proethos Fond
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Storebrand Grön Obligation A SEK
Sweden
9.14 %
2. Vertex Pharmaceuticals Inc
9.35 %
2. Shimano ADR
Japan
5.63 %
3. Moderna Inc
9.21 %
3. Vestas Wind Systems A/S
Denmark
5.47 %
4. Alnylam Pharmaceuticals Inc
6.96 %
4. Central Japan Railway Co
Japan
4.98 %
5. AbbVie Inc
USA
5.53 %
5. NIBE Industrier B
Sweden
4.69 %
6. Gilead Sciences Inc
USA
4.66 %
6. Nordex SE
Germany
4.66 %
7. Amgen Inc
4.3 %
7. Ormat Technologies Inc
USA
4.46 %
8. BioNTech SE
4.13 %
8. First Solar Inc
USA
4.26 %
9. Karuna Therapeutics Inc
3.75 %
9. Enphase Energy Inc
USA
1.72 %
10. Royalty Pharma Plc
3.37 %
-

The list of fund holdings was last updated on June 5, 2025.